NCT03913559 2026-02-12
Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia
St. Jude Children's Research Hospital
Phase 2 Terminated
Clinical Trials
1 trialsPrecursor Cell Lymphoblastic Leukemia-Lymphoma × Methylprednisolone Hemisuccinate × 90 days × Clear all